Skip to search formSkip to main contentSkip to account menu

Serotonin Degradation

Known as: serotonin breakdown, serotonin catabolic process, serotonin catabolism 
By induction of conjugation, transport, and/or oxidation, Serotonin Degradation consists of breakdown of a secreted biochemical messenger and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors
Neuroendocrine tumors (NETs) arising in the small intestine are known to produce vasoactive substances, including serotonin, that… 
2007
2007
Serotonin catabolism in the central and enteric nervous systems of rats upon induction of serotonin syndrome
Serotonin, a well‐known neurotransmitter in mammals, has been linked to a number of neurological and gastrointestinal disorders… 
2005
2005
Pharmacological Manipulation of Serotonin Levels in the Nervous System of the Opisthobranch Mollusc Tritonia diomedea
Serotonin-related disorders can be treated by manipulating serotonin synthesis with the serotonin precursor 5-hydroxytryptophan… 
2003
2003
Paroxetine withdrawal in a neonate with historical and laboratory confirmation
We describe a term neonate born to a mother who stopped paroxetine intake 48 h prior to birth, who had features suggestive of… 
2003
2003
Monoamine oxidase A-deficiency and noradrenergic respiratory regulations in neonatal mice
2002
2002
Phentermine inhibition of recombinant human liver monoamine oxidases A and B.
2002
2002
Increase in Expression of Brain Serotonin Transporter and Monoamine Oxidase A Genes Induced by Repeated Experience of Social Defeats in Male Mice
Serotonin transporter and monoamine oxidase (MAO) A are involved in the inactivation of serotonin. The former is responsible for… 
1986
1986
Serotoninergic inhibition of LH secretion in the domestic fowl.
Immature cockerels were injected with drugs known to affect serotoninergic activity. The receptor agonist quipazine as well as… 
1966
1966
Differences between amine oxidases deaminating mescaline and the structurally related 3,4-dimethoxyphenylethyl amine.
1959
1959
Observations on the psychotogenic effect of N-N diethyltryptamine, a new tryptamine derivative.
After discussing the hallucinogenic derivatives of tryptamine known thus far and their significance, the authors outline the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)